Table 1
Triple end point rates (death, MI or recurrent angina)
Time
UFH (n = 1564)
Enoxaparin (n = 1607)
Relative risk reduction (%)
p Value
48 hours
115 (7.4)
99 (6.2)
16.2
0.176
14 days
309 (19.8)
266 (16.6)
16.2
0.019
30 days
364 (23.3)
318 (19.8)
15.0
0.017
Values are n (%).